Prospect Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$322K Sell
2,219
-480
-18% -$66.3K 0.27% 47
2026
Q2
$347K Buy
2,699
+76
+3% +$8.9K 0.28% 49
2026
Q1
$316K Buy
2,623
+17
+0.7% +$1.96K 0.29% 45
2025
Q4
$274K Sell
2,606
-136
-5% -$12.8K 0.26% 48
2025
Q3
$230K Sell
2,742
-104
-4% -$8.57K 0.22% 53
2025
Q2
$225K Sell
2,846
-142
-5% -$11.3K 0.24% 53
2025
Q1
$268K Buy
2,988
+430
+17% +$40.1K 0.34% 47
2024
Q4
$254K Buy
+2,558
New +$264K 0.31% 45

Other funds holding MRK

Prospect Financial Group's MRK Position: Q3 2026 in Review

Prospect Financial Group reduced its Merck (MRK) stake by 18% in Q3 2026, selling an estimated $66.3K and leaving 2,219 shares worth $322K. The position accounts for 0.27% of the portfolio, ranked #47.

Prospect Financial Group first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. The position peaked at $347K in Q2 2026. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Prospect Financial Group held 2,219 shares of Merck worth $322K as of Q3 2026.
  • Prospect Financial Group sold 480 Merck shares in Q3 2026, an estimated $66.3K.
  • Merck made up 0.27% of Prospect Financial Group's portfolio in Q3 2026, its #47 holding.
  • Prospect Financial Group first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • Prospect Financial Group's Merck position peaked at $347K in Q2 2026.
  • 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Prospect Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.